Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;40:713-720
Published online before print October 7, 2002, doi: 10.1161/01.HYP.0000037429.73954.27
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/713    most recent
01.HYP.0000037429.73954.27v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-Peña, A.
Right arrow Articles by López-Novoa, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-Peña, A.
Right arrow Articles by López-Novoa, J. M.
Related Collections
Right arrow Animal models of human disease
Right arrow Genetically altered mice

(Hypertension. 2002;40:713.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in Mice

Ana Rodríguez-Peña; Nélida Eleno; Anette Düwell; Miguel Arévalo; Fernando Pérez-Barriocanal; Olga Flores; Neil Docherty; Carmelo Bernabeu; Michelle Letarte; José M. López-Novoa

From Instituto "Reina Sofía" de Investigación Nefrológica, Departamento de Fisiología & Farmacología (A.R.-P., N.E., A.D., F.P.-B., O.F., N.D., J.M.L.-N.), and Departamento de Anatomía e Histología Humanas (M.A.), Universidad de Salamanca, Salamanca, Spain; Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (C.B.), Madrid, Spain; and Hospital for Sick Children and Department of Immunology, University of Toronto (M.L.), Toronto, Canada.

Correspondence to José M. López-Novoa, PhD, Departamento de Fisiología y Farmacología, Edificio Departamental, Campus Miguel de Unamuno, 37007 Salamanca, Spain. E-mail jmlnovoa{at}gugu.usal.es

The goal of the present study was to evaluate the role of endoglin, a transforming growth factor-ß1 (TGF-ß1) accessory receptor, in the pathogenesis of renal fibrosis. This was achieved by testing a model of tubulo-interstitial fibrosis induced by unilateral ureteral obstruction in endoglin heterozygous (Eng+/-) mice. Northern and Western blot analysis revealed that endoglin expression in kidneys of these mice was significantly reduced compared with Eng+/+ littermates. Pronounced interstitial fibrosis induced by ureteral obstruction was confirmed histologically by Masson’s trichromic staining and by increased immunostaining for fibronectin and laminin without significant differences between Eng+/- and Eng+/+ mice. Ureteral obstruction induced significant increases in {alpha}2(I) and {alpha}1(IV) collagen, fibronectin, and TGF-ß1 mRNA levels, as well as in total kidney collagen but changes were similar in Eng+/- and Eng+/+ mouse kidneys. Ureteral obstruction also induced a 2-fold increase in endoglin mRNA levels in both Eng+/+ mice and Eng+/- mice, which was confirmed by Western blot analysis. Thus, the present study provides clear evidence that endoglin is upregulated in the kidneys of mice with interstitial fibrosis induced by unilateral ureteral ligation. However, Eng+/- mice do not show any changes in the severity of renal disease induced in this model when compared with normal mice, suggesting that the absolute level of endoglin is not critical for the effects of TGF-ß1 in the renal fibrosis process.


Key Words: collagen • renal disease • fibrosis • transforming growth factors




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Jerkic, J. V. Rivas-Elena, J. F. Santibanez, M. Prieto, A. Rodriguez-Barbero, F. Perez-Barriocanal, M. Pericacho, M. Arevalo, C. P.H. Vary, M. Letarte, et al.
Endoglin Regulates Cyclooxygenase-2 Expression and Activity
Circ. Res., August 4, 2006; 99(3): 248 - 256.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. G. Docherty, J. M. Lopez-Novoa, M. Arevalo, A. Duwel, A. Rodriguez-Pena, F. Perez-Barriocanal, C. Bernabeu, and N. Eleno
Endoglin regulates renal ischaemia-reperfusion injury
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2106 - 2119.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Roufosse, G. Bou-Gharios, E. Prodromidi, C. Alexakis, R. Jeffery, S. Khan, W. R. Otto, J. Alter, R. Poulsom, and H. T. Cook
Bone Marrow-Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 775 - 782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. G. Docherty, O. E. O'Sullivan, D. A. Healy, J. M. Fitzpatrick, and R. W. G. Watson
Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction
Am J Physiol Renal Physiol, January 1, 2006; 290(1): F4 - F13.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Chen, J. L. Mehta, D. Li, L. Joseph, and J. Joseph
Transforming Growth Factor {beta} Receptor Endoglin Is Expressed in Cardiac Fibroblasts and Modulates Profibrogenic Actions of Angiotensin II
Circ. Res., December 10, 2004; 95(12): 1167 - 1173.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Sadlier, S. B. Connolly, N. E. Kieran, S. Roxburgh, D. P. Brazil, L. Kairaitis, Y. Wang, D. C. H. Harris, P. Doran, and H. R. Brady
Sequential Extracellular Matrix-focused and Baited-global Cluster Analysis of Serial Transcriptomic Profiles Identifies Candidate Modulators of Renal Tubulointerstitial Fibrosis in Murine Adriamycin-induced Nephropathy
J. Biol. Chem., July 9, 2004; 279(28): 29670 - 29680.
[Abstract] [Full Text] [PDF]